Sanara MedTech Inc.
Sanara MedTech Inc. (NASDAQ: SMTI) is trading at $35.09, about ₹3,371 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 0.03% today. Indian residents can buy Sanara MedTech from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$35.03
Today's high
$35.16
52 week low
$16.05
52 week high
$35.34
SMTI opened at $35.16, closed previously at $35.10, and has traded between $16.05 and $35.34 over the past 52 weeks.
About
Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities. The company's extensive product portfolio includes CellerateRX, a line of Surgical Activated Collagen in both powder and gel forms, designed to enhance patient healing across various surgical specialties. Sanara MedTech also offers a suite of Biako's antimicrobial products: a patented Skin and Wound Cleanser engineered to dismantle mature biofilm microbes by disrupting their extracellular polymeric substances, an Antimicrobial Wound Gel effective against both planktonic and biofilm-forming microbes, and an Antimicrobial Skin and Wound Irrigation Solution. Another key offering is HYCOL, a hydrolyzed Type I bovine collagen available as powder and gel, specifically formulated for the management of both full and partial thickness wounds, encompassing conditions such as pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. Additionally, Sanara MedTech is involved in the development of sophisticated biologic devices like FORTIFY TRG, a freeze-dried, multi-layer sheet derived from small intestinal submucosa extracellular matrix, and FORTIFY FLOWABLE extracellular matrix, an innovative wound care solution. The company also provides VIM Amnion Matrix, a single-layer amnion tissue sheet. Initially incorporated as WNDM Medical Inc., the company underwent a name change to Sanara MedTech Inc. in May 2019.
Key statistics
Avg. volume
200.08K
Market cap
$322.58M
P/E Ratio
-9.44
Price-to-sales ratio
2.94
Enterprise value
$232.96M
Free cash flow yield
1.07%
Debt-to-equity ratio
6.11
Return on equity
-633.46%
ROIC
16.73%
Beta
1.16
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$103.12M
Earnings per share
-$4.36
Free cash flow
$2.16M
Net profit margin
-29.15%
Gross margin
91.33%
EBITDA
$9.03M
Revenue growth
18.97%
Similar securities
This is not an investment recommendation
How to buy Sanara MedTech from India
Indian residents can buy Sanara MedTech shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Sanara MedTech and place an order
Find Sanara MedTech by name or by its ticker, SMTI, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Sanara MedTech trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Sanara MedTech position in USD and INR. Sanara MedTech pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Sanara MedTech from India
Trading and taxes when buying Sanara MedTech from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneSanara MedTech does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Sanara MedTech stock?
Yes. Sanara MedTech (SMTI) has been listed on NASDAQ since 1994, in the Medical - Instruments & Supplies industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Sanara MedTech share cost in rupees?
One Sanara MedTech share is $35.09 — about ₹3,371 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Sanara MedTech price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Sanara MedTech from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Sanara MedTech?
Yes. One Sanara MedTech share is $35.09, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Sanara MedTech.
How are gains on Sanara MedTech shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Sanara MedTech price. Paasa issues a capital-gains statement for your return.
Does Sanara MedTech pay a dividend?
No. Sanara MedTech does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Sanara MedTech from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Sanara MedTech shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Sanara MedTech shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Sanara MedTech holding, its cost and its closing value.
How do I sell Sanara MedTech and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.